Evidence map›Paper›PMID 33743726›Full record

ArticleAnnals of clinical microbiology and antimicrobials2021

Intestinal carriage of vancomycin-resistant Enterococcus spp. among high-risk patients in university hospitals in Serbia: first surveillance report.

Ana Janjusevic, Ljiljana Markovic Denic, Rajna Minic, Anita Grgurevic, Ivana Cirkovic

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. High Gastrointestinal Colonization Rate of Vancomycin-ResistantInternational journal of microbiology · 2024
    Article
  4. Article
  5. Predictors of Vancomycin-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ana JanjusevicDepartment of Bacteriology, Institute of Virology, Vaccines and Sera "Torlak", Vojvode Stepe 458, 11152, Belgrade, Serbia. dr.ana.janjusevic@gmail.com.ORCID http://orcid.org/0000-0002-5759-3527
Ljiljana Markovic DenicDepartment of Epidemiology, Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Visegradska 26a, PO Box 20, 11129, Belgrade, Serbia.
Rajna MinicDepartment of Bacteriology, Institute of Virology, Vaccines and Sera "Torlak", Vojvode Stepe 458, 11152, Belgrade, Serbia.
Anita GrgurevicDepartment of Epidemiology, Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Visegradska 26a, PO Box 20, 11129, Belgrade, Serbia.
Ivana CirkovicDepartment of Bacteriology, Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Dr Subotića 1, 11000, Belgrade, Serbia.
University of Belgrade · RSInstitute of Virology, Vaccines and Sera “Torlak” · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe screening for intestinal carriage of vancomycin-resistant Enterococcus spp. (VRE) among high risk patients in the Balkan region and molecular epidemiology of VRE is insufficiently investigated, yet it could be of key importance in infection control. The aim of this study was to provide baseline data on VRE intestinal carriage among high-risk patients in Serbian university hospitals, to determine the phenotypic/genotypic profiles of the isolated VRE, to obtain knowledge of local resistance patterns and bridge the gaps in current VRE surveillance.

methodsThe VRE reservoir was investigated using stool samples from 268 inpatients. Characterization of isolated VRE stains consisted of BD Phoenix system, genotypic identification, glycopeptide and quinupristin-dalfopristin (Q-D) resistance probing, virulence gene (esp, hyl, efaA, asa1, gelE, cpd) detection and MLVA. Biofilm formation was evaluated by the microtiter plate method.

resultsVRE carriage prevalence among at-risk patients was 28.7%. All VRE strains were vanA positive multidrug-resistant Enterococcus faecium (VRfm), harboring ermB-1 (38.9%), esp (84%), efaA (71.2%), hyl (54.5%), asa1 (23.4%), gelE and cpd (11.6%) each. Ability of biofilm production was detected in 20.8%. Genetic relatedness of the isolates revealed 13 clusters, heterogeneous picture and 25 unique MTs profiles.

conclusionThe obtained prevalence of VRE intestinal carriage among high-risk inpatients in Serbia is higher than the European average, with high percentage of multidrug resistance. The emergence of resistance to Q-D is of particular concern. Close monitoring of pattern of resistance and strict adherence to specific guidelines are urgently needed in Serbia.

Indexed as

Drug Resistance, Multiple, BacterialHospitals, UniversityAnti-Bacterial AgentsBacterial ProteinsBiofilmsEnterococcusEnterococcus faeciumGenotypeGram-Positive Bacterial InfectionsHumansMicrobial Sensitivity TestsMolecular EpidemiologySerbiaVancomycinVancomycin-Resistant EnterococciVirulenceAnti-Bacterial AgentsBacterial ProteinsVancomycinVirulence FactorsAntibiotic susceptibilityMLVA sreeningSerbiaVRE carriage

Identifiers

PMID33743726
PMCPMC7981873
OpenAlexW3136195936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.